Concurrent Sorafenib and Radiotherapy versus Radiotherapy Alone for Locally Advanced Hepatocellular Carcinoma: A Propensity-Matched Analysis.
Chieh-Min LiuBing-Shen HuangYi-Hao YenYu-Ming WangEng-Yen HuangHsuan-Chih HsuTzu-Ting HuangYao-Hsu YangJen-Yu ChengPublished in: Journal of hepatocellular carcinoma (2021)
In our study, the concurrent use of sorafenib and conventional external beam radiotherapy shows no survival benefit over radiotherapy alone for locally advanced hepatocellular carcinoma.